These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

366 related items for PubMed ID: 29797086

  • 1. Management of Non-Diffuse Large B Cell Lymphoma Post-Transplant Lymphoproliferative Disorder.
    Major A, Kamdar M.
    Curr Treat Options Oncol; 2018 May 24; 19(7):33. PubMed ID: 29797086
    [Abstract] [Full Text] [Related]

  • 2. Post-transplant lymphoproliferative disorders.
    Singavi AK, Harrington AM, Fenske TS.
    Cancer Treat Res; 2015 May 24; 165():305-27. PubMed ID: 25655616
    [Abstract] [Full Text] [Related]

  • 3. [Post-transplant lymphoproliferative disorder: a clinicopathologic study of 15 cases].
    Chen DB, Wang Y, Song QJ, Shen DH.
    Zhonghua Bing Li Xue Za Zhi; 2012 Sep 24; 41(9):607-12. PubMed ID: 23157829
    [Abstract] [Full Text] [Related]

  • 4. Prospective Epstein-Barr virus-related post-transplant lymphoproliferative disorder prevention program in pediatric allogeneic hematopoietic stem cell transplant: virological monitoring and first-line treatment.
    Chiereghin A, Prete A, Belotti T, Gibertoni D, Piccirilli G, Gabrielli L, Pession A, Lazzarotto T.
    Transpl Infect Dis; 2016 Feb 24; 18(1):44-54. PubMed ID: 26574232
    [Abstract] [Full Text] [Related]

  • 5. Post-transplant lymphoproliferative disorders.
    Gottschalk S, Rooney CM, Heslop HE.
    Annu Rev Med; 2005 Feb 24; 56():29-44. PubMed ID: 15660500
    [Abstract] [Full Text] [Related]

  • 6. Post-transplant lymphoproliferative disorders (PTLD) after solid organ transplantation.
    Taylor AL, Marcus R, Bradley JA.
    Crit Rev Oncol Hematol; 2005 Oct 24; 56(1):155-67. PubMed ID: 15979320
    [Abstract] [Full Text] [Related]

  • 7. Epstein-Barr virus post-transplant lymphoproliferative disease (PTLD) after hematopoietic stem cell transplantation.
    Ru Y, Chen J, Wu D.
    Eur J Haematol; 2018 Sep 24; 101(3):283-290. PubMed ID: 29949208
    [Abstract] [Full Text] [Related]

  • 8. Reduction of immunosuppression combined with whole-brain radiotherapy and concurrent systemic rituximab is an effective yet toxic treatment of primary central nervous system post-transplant lymphoproliferative disorder (pCNS-PTLD): 14 cases from the prospective German PTLD registry.
    Zimmermann H, Nitsche M, Pott C, Reinke P, Babel N, Hermann RM, Hauser IA, Hahn D, Ritgen M, Pietschmann C, Klapper W, Anagnostopoulos I, Trappe RU, German PTLD Study Group and German Lymphoma Alliance.
    Ann Hematol; 2021 Aug 24; 100(8):2043-2050. PubMed ID: 33973053
    [Abstract] [Full Text] [Related]

  • 9. Managing the challenge of PTLD in liver and bowel transplant recipients.
    Lauro A, Arpinati M, Pinna AD.
    Br J Haematol; 2015 Apr 24; 169(2):157-72. PubMed ID: 25377273
    [Abstract] [Full Text] [Related]

  • 10. Outcome of treatment of Epstein-Barr virus-related post-transplant lymphoproliferative disorder in hematopoietic stem cell recipients: a comprehensive review of reported cases.
    Styczynski J, Einsele H, Gil L, Ljungman P.
    Transpl Infect Dis; 2009 Oct 24; 11(5):383-92. PubMed ID: 19558376
    [Abstract] [Full Text] [Related]

  • 11. Induction regimens and post-transplantation lymphoproliferative disorder after pediatric intestinal transplantation: Single-center experience.
    Devine K, Ranganathan S, Mazariegos G, Bond G, Soltys K, Ganoza A, Sun Q, Sindhi R.
    Pediatr Transplant; 2020 Aug 24; 24(5):e13723. PubMed ID: 32424963
    [Abstract] [Full Text] [Related]

  • 12. Post-transplantation lymphoproliferative disorder in heart and kidney transplant patients: a single-center experience.
    Wasson S, Zafar MN, Best J, Reddy HK.
    J Cardiovasc Pharmacol Ther; 2006 Mar 24; 11(1):77-83. PubMed ID: 16703222
    [Abstract] [Full Text] [Related]

  • 13. Post-transplant lymphoproliferative disorder.
    Kalinova L, Indrakova J, Bachleda P.
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2009 Dec 24; 153(4):251-7. PubMed ID: 20208963
    [Abstract] [Full Text] [Related]

  • 14. [Post-transplant lymphoproliferative disease in liver transplant recipients--Merkur University Hospital single center experience].
    Filipec-Kanizaj T, Budimir J, Colić-Cvrlje V, Kardum-Skelin I, Sustercić D, Naumovski-Mihalić S, Mrzljak A, Kolonić SO, Sobocan N, Bradić T, Dolić ZM, Kocman B, Katicić M, Zidovec-Lepej S, Vince A.
    Acta Med Croatica; 2011 Sep 24; 65 Suppl 1():37-43. PubMed ID: 23126028
    [Abstract] [Full Text] [Related]

  • 15. Post-transplantation lymphoproliferative disorders: diagnosis, prognosis, and current approaches to therapy.
    Evens AM, Roy R, Sterrenberg D, Moll MZ, Chadburn A, Gordon LI.
    Curr Oncol Rep; 2010 Nov 24; 12(6):383-94. PubMed ID: 20963522
    [Abstract] [Full Text] [Related]

  • 16. Diagnosis and treatment of post-transplantation lymphoproliferative disorder in pediatric heart transplant patients.
    Schubert S, Abdul-Khaliq H, Lehmkuhl HB, Yegitbasi M, Reinke P, Kebelmann-Betzig C, Hauptmann K, Gross-Wieltsch U, Hetzer R, Berger F.
    Pediatr Transplant; 2009 Feb 24; 13(1):54-62. PubMed ID: 18518912
    [Abstract] [Full Text] [Related]

  • 17. Low incidence of posttransplant lymphoproliferative disorder after allogeneic stem cell transplantation in patients with lymphoma treated with rituximab.
    Fujimoto A, Hiramoto N, Yamasaki S, Inamoto Y, Ogata M, Sugio Y, Fukuda T, Uchida N, Ikegame K, Matsuoka KI, Shiratori S, Kondo T, Miyamoto T, Eto T, Ichinohe T, Kanda Y, Atsuta Y, Suzuki R, Complication Working Group of the Japan Society for Hematopoietic Cell Transplantation.
    Hematol Oncol; 2020 Apr 24; 38(2):146-152. PubMed ID: 31953867
    [Abstract] [Full Text] [Related]

  • 18. [Early diagnosis and comprehensive treatments of post-transplantation lymphoproliferative disorder after pediatric liver transplantation].
    Deng Z, Jiang L, Zhou T, Shen C, Chen Q, Xia Q.
    Zhonghua Er Ke Za Zhi; 2014 Aug 24; 52(8):579-82. PubMed ID: 25224233
    [Abstract] [Full Text] [Related]

  • 19. Epstein-Barr virus-related post-transplant lymphoproliferative disorder in solid organ transplant recipients.
    San-Juan R, Comoli P, Caillard S, Moulin B, Hirsch HH, Meylan P, ESCMID Study Group of Infection in Compromised Hosts.
    Clin Microbiol Infect; 2014 Sep 24; 20 Suppl 7():109-18. PubMed ID: 24475976
    [Abstract] [Full Text] [Related]

  • 20. [Treatment of post-transplant lymphoproliferative disease with rituximab].
    Jiang YJ, Wang X.
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Jun 24; 22(3):852-6. PubMed ID: 24989308
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.